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The ability of cocoa to interact with the immune system in vitro and in vivo has been 
described. In the latter context, a cocoa-enriched diet in healthy rats was able to mod-
ify the immune system’s functionality. This fact could be observed in the composition 
and functionality of lymphoid tissues, such as the thymus, spleen, and lymph nodes. 
Consequently, immune effector mechanisms, such as antibody synthesis, were modified. 
A cocoa-enriched diet in young rats was able to attenuate the serum levels of immuno-
globulin (Ig) G, IgM, and IgA and also the intestinal IgM and IgA secretion. Moreover, in 
immunized rats, the intake of cocoa decreased specific IgG1, IgG2a, IgG2c, and IgM 
concentrations in serum. This immune-regulator potential was then tested in disease 
models in which antibodies play a pathogenic role. A cocoa-enriched diet was able to 
partially prevent the synthesis of autoantibodies in a model of autoimmune arthritis in 
rats and was also able to protect against IgE and T helper 2-related antibody synthesis 
in two rat models of allergy. Likewise, a cocoa-enriched diet prevented an oral sensiti-
zation process in young rats. In this review, we will focus on the influence of cocoa on 
the acquired branch of the immune function. Therefore, we will focus on how a cocoa 
diet influences lymphocyte function both in the systemic and intestinal immune system. 
Likewise, its potential role in preventing some antibody-induced immune diseases is also 
included. Although further studies must characterize the particular cocoa components 
responsible for such effects and nutritional studies in humans need to be carried out, 
cocoa has potential as a nutraceutical agent in some hypersensitivity status.
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iNTRODUCTiON
Antibody response is a kind of acquired immune response produced by complex interactions 
between several types of immune cells after the entry of an antigen into the body. In brief, when 
dendritic cells come into contact with an antigen in the skin or the mucosa, they become antigen-
presenting cells and will be in charge of finding specific helper (Th) cells in order to trigger an 
acquired immune response (1). Activated specific Th cells will differentiate into effector T  cells 
that, by means of different patterns of cytokines, will enhance the function of cells, such as 
B lymphocytes, macrophages, natural killer (NK) cells, cytotoxic T (Tc) lymphocytes, mast cells, 
or eosinophils. The activation of B cells, mainly related to Th2-immune response, will produce the 
formation of plasma cells that will eventually synthesize antibodies against the triggering antigen (1). 
In addition, inside the germinal centers of the secondary lymphoid tissues, another kind of antigen 
presentation occurs. Follicular dendritic cells (FDC) retain the native antigen that could prime 
TAble 1 | Summary of the effects of cocoa diet in serum immunoglobulins and specific antibodies in healthy rats.
Strain initial age (weeks) Cocoa dose length of the study (weeks) Results Reference
Wistar rats 3 4% by oral gavage 3 =IgG (18)
=IgM
=IgA
10% in the food 3 ↓IgG
↓IgM
↓IgA
Wistar rats 6 2% in the food 3 =IgG1, IgG2a, IgG2b, IgG2c (20)
=IgM
=IgA
5% in the food 3 =IgG1, IgG2b, ↓IgG2a, ↑IgG2c
=IgM
=IgA
10% in the food 3 =IgG1, IgG2b, IgG2c, ↓IgG2a
↓IgM
=IgA
Wistar rats 4 10% in the food 7 =IgG1, IgG2a, IgG2c, ↓IgG2b (19)
↓IgM
↓IgA
Wistar rats 3 4% in the food 9 =Specific IgG2a, IgG2b (21)
↓Specific IgG1, IgG2c
↓Specific IgM
10% in the food 9 ↓Specific IgG1, IgG2a, IgG2c
↑Specific IgG2b
↓Specific IgM
Arrows indicate increases or decreases, equals sign means no changes.
Ig, immunoglobulins.
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B cells to synthesized specific antibodies (2, 3). The FDC can form 
immune complex-coated bodies known as iccosomes that could 
also affect B  cell activation, maturation, and maintenance (4). 
Whereas antibodies will neutralize or facilitate antigen destruc-
tion, sometimes, such as in hypersensitivity and autoimmune 
reactions, they could have a harmful effect on the body.
Although the earliest evidence for the medical use of cocoa 
was found in Mesoamerican civilizations (5), nowadays, the 
healthy properties of cocoa and its derivatives are re-emerging. 
In addition to the effects of cocoa on cardiovascular health 
(6, 7), the nervous system (8), and cancer (9–11), cocoa also 
has an effect on the immune system. The immunomodulatory 
properties of cocoa include its potential anti-inflammatory 
role, demonstrated in both in vitro and in vivo studies (12–14). 
However, only few clinical studies with this aim have been carried 
out, and recently it was suggested that there is scarce evidence of 
the anti-inflammatory effects of cocoa consumption in humans 
(15). Nevertheless, researchers in this field have joined on several 
occasions to discuss in depth the effects of chocolate and cocoa 
on medicine and have demonstrated the increasing emergence of 
cocoa as a diet compound able to prevent some diseases, or even 
being a coadjuvant in some therapies (16, 17). In this review, we 
will focus on the influence of cocoa on the acquired branch of the 
immune function. Therefore, we will focus on how a cocoa diet 
influences lymphocyte function both in the systemic and intes-
tinal immune system. Likewise its potential role in preventing 
some antibody-induced immune diseases is also included.
COCOA iNFlUeNCeS SYSTeMiC 
ANTibODY SYNTHeSiS
Preclinical studies performed 10  years ago showed for the 
first time the in vivo influence of a cocoa diet on the immune 
system (14, 18). These studies were carried out in young rats 
that were fed a diet containing 10% cocoa or in rats that were 
orally administered with a dose equivalent to 4% cocoa in food 
intake for 3 weeks. Results showed that the 10% cocoa-enriched 
diet, but not the 4% dose, was able to decrease serum immu-
noglobulin (Ig) G, IgM, and IgA concentrations (18) (Table 1). 
A further analysis of IgG isotypes showed that 3-week-old rats 
fed a 10% cocoa diet for 3 weeks resulted in attenuated levels of 
IgG2b antibodies but increased levels of IgG2a (19) (Table 1). 
However, in a study in which the cocoa diet was given later, 
at 6 weeks of age, the 10% cocoa-enriched diet was associated 
with lower values of serum IgG2a but higher serum IgG2c con-
centrations than those present in animals fed the standard diet 
(20) (Table  1). Moreover, it was observed that the minimum 
dose to achieve such an effect was 5% cocoa in the diet (20) 
and, at any rat age, a 5 or 10% cocoa diet attenuated the serum 
levels of IgM and IgA (19, 20), the effects being clearer when 
animals were younger and the diet lasted longer. Therefore, 
these studies in rats showed that a cocoa diet influences sys-
temic immunoglobulin production but the effect depends on 
the antibody isotype, the age of the animal, and the length of 
the cocoa intervention.
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Apart from the cocoa’s influence on basal serum immu-
noglobulin levels, it was interesting to shed some light on the 
antibody response in rats after a specific challenge, i.e., in immu-
nized rats. In these conditions, animals were fed cocoa before 
and during an immunization process, and the overall synthesis of 
specific antibodies was also lowered (21) (Table 1). Specifically, 
the accurate analysis of antibodies revealed that the most attenu-
ated isotypes were specific IgM, IgG1, IgG2a, and IgG2c antibod-
ies, whereas specific IgG2b concentrations held steady or even 
increased with the 10% cocoa diet. As IgG rat isotypes can be 
associated with Th1 (IgG2b) or Th2 (IgG1 and IgG2a) immune 
response (22), these results may suggest a regulatory effect of 
cocoa in Th2-immune responses. This lowering effect on specific 
IgG1 and IgG2a, and therefore on Th2-related response, could be 
associated with cocoa polyphenols given that other polyphenols, 
such as genistein, chrysin, and apigenin (23, 24), and those from 
apple or soybean caused similar results (23, 25).
After establishing cocoa’s influence on immunoglobulin syn-
thesis, the reason why this diet produced such an effect remained 
to be studied.
COCOA iNFlUeNCeS COMPOSiTiON 
AND FUNCTiONAliTY OF PRiMARY  
AND SeCONDARY lYMPHOiD TiSSUeS
To ascertain the mechanisms induced by cocoa on the antibody 
immune response, lymphoid tissue composition and lympho-
cyte functionality were then determined. In addition, as cocoa 
intake can interact with gut-associated lymphoid tissue (GALT), 
several investigations were carried out to ascertain the influ-
ence of cocoa in this particular compartment of the immune 
system. Preclinical studies carried out in rats demonstrated 
that a cocoa diet modifies lymphoid tissue composition and 
function (13). Lymphoid tissues are considered as primary or 
secondary depending on whether they are devoted either to the 
formation of the lymphocyte repertoire or to the development 
of the immune response, respectively (26). Thymus is a primary 
lymphoid tissue where T-cell maturation takes place, whereas 
lymph nodes, spleen, and mucosal lymphoid tissue belong to the 
secondary lymphoid tissue category (27).
Cocoa and Systemic lymphoid Tissue 
Composition
It was demonstrated that Wistar rats receiving a 10% cocoa 
diet for 3  weeks accumulate cocoa polyphenol metabolites 
in immune tissues, such as the thymus, lymph nodes, and 
spleen (28). In particular, the highest accumulation was in the 
thymus, where phenotypic changes were found due to the diet. 
In particular, cocoa intake resulted in an enhancement of the 
progression of immature thymocytes (those with low expres-
sion of the αβ T-cell receptor—TCR αβ−, and expressing or 
non-expressing the clusters of differentiation CD4 and CD8, 
i.e., TCRαβlowCD4−CD8− or TCRαβlowCD4+CD8+) toward more 
mature stages (TCRαβhighCD4+CD8−) (29) (Table 2). In spite of 
this increase in CD4+ (Th) cells in the thymus, the analysis of a 
secondary lymphoid tissue, such as the spleen, revealed that a 
10% cocoa diet in young rats for 3 weeks increased the propor-
tion of spleen B cells and decreased that of Th lymphocytes (18) 
(Table 2).
Lymph nodes were also affected by a cocoa diet. In particu-
lar, in mesenteric lymph nodes, a cocoa-enriched diet for 3 or 
4 weeks in rats increased the proportion of innate cytotoxic lym-
phocytes, such as cells expressing γδ T-cell receptor (TCRγδ+) 
and NK cells, and also that of the Tc lymphocytes and B cells, 
whereas the proportion of Th cells decreased (30, 31) (Table 2). 
These effects were only produced by a 10% cocoa diet whereas 
a 4% cocoa dose was insufficient to influence the phenotype 
of mesenteric lymph nodes (30). Similarly, the intake of a 10% 
cocoa-enriched diet given to rats for 6 weeks decreased the pro-
portion of TCRαβ+ cells but did not modify that of regulatory 
T cells (Treg) in inguinal lymph nodes in rats (32) (Table 2).
A more in-depth analysis of lymphocytes in mesenteric 
lymph nodes revealed that the increase of TCRγδ+ cells was 
attributed to the presence of a higher amount of CD8αα+ cells, 
a typical intestinal phenotype, which could be due to the migra-
tion of this cellular type from the intestine (34). The increase 
of Tc cells in mesenteric lymph nodes was accompanied by a 
higher proportion of activated cells (CD25+CD8+ cells) and cells 
expressing the αE-integrin (CD103+CD8+ cells) and a lower 
proportion of cells bearing L-selectin (CD62L+CD8+ cells) 
(31) (Table 2). CD103 is a subunit of the αE-integrin that can 
mediate cell adhesion and migration to the gut (35), whereas 
L-selectin is involved in lymphocyte rolling on the endothelium 
and the homing to secondary lymphoid tissues (36). These 
results could mean that the cocoa diet decreased the arrival of 
blood lymphocytes to mesenteric lymph nodes whereas it may 
favor intestinal cells entering. As cocoa compounds can reach 
the small intestine and even the colon (37, 38), they can affect 
the intestinal lymphocytes and promote their migration to 
mesenteric lymph nodes.
Overall, the increased proportion of CD8αα+TCRγδ+ cells, 
NK cells, and CD103+ Tc cells in mesenteric lymph nodes could 
be involved in cocoa’s influence on antibody immune response. 
TCRγδ+ cells have been associated with an attenuating effect on 
the synthesis of antibodies (39), and NK  cells could also con-
tribute to the regulation of antibody synthesis (40). Moreover, 
CD103+ cells have been associated with a regulatory function 
given that their proportion increased after treatment with immu-
nosuppressive agents (41).
After feeding a cocoa-enriched diet, cocoa flavonoid metabo-
lites are stored in the lymphoid tissues (thymus, lymph nodes, 
and spleen) as well as in the liver. In fact, epicatechin metabolites 
have been reported to be accumulated in concentrations twofold 
higher in the thymus, testes, and liver than in lymph nodes and 
spleen (28). With regard to the liver, the 10% cocoa intake in 
rats enhanced hepatic antioxidant capacity, without modifying 
hepatic superoxide dismutase and catalase activities (29).
Cocoa and lymphocyte Function
The development of the acquired immune response implies the 
involvement of complex interactions between immune cells 
TAble 2 | Summary of the effects of cocoa diet in lymphocyte composition of lymphoid tissues.
lymphoid tissue Cocoa dose length of the diet (weeks) Results (% cells) Reference
Thymus 10% in the food 3 ↓TCRαβlowCD4−CD8− (29)
↓TCRαβlowCD4+CD8+
↑TCRαβhighCD4+CD8−
Spleen 4% by oral gavage 3 No changes (18)
10% in the food ↑B
↓Th
Lymph nodes 4% by oral gavage 3 No changes (30)
10% in the food ↑TCRγδ+
↓Th
↑Tc





↑Tc (↑CD25+, ↑CD103+, ↓CD62L+)




Peyer’s patches 4% by oral gavage 3 No changes (30)




10% in the food 4 ↑TCRγδ+ (33)
↑NKT
↓Th (↑ CD25+, ↑CD103+, ↓CD62L+)
=Tc (↑ CD103+)




Intestinal lamina propria 10% in the food 4 ↓NKT (33)
↓IgA+
Arrows indicate increases or decreases, equals sign means no changes.
CD, cluster of differentiation; TCRαβlow, cells with low expression of αβ T-cell receptor; Th, T helper lymphocytes; Tc, T cytotoxic lymphocytes; TCRγδ+, cells with γδ T-cell receptor; 
NK, natural killer cells; NKT, natural killer T cells; Treg, T regulatory cells; TLR, toll-like receptor; Ig, immunoglobulin.
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by means of particular surface molecules and the secretion of 
cytokines. The gene or protein expression of those molecules 
involved in the immune synapses, as well as cytokines and other 
molecules secreted by immune cells, can be evaluated.
In vitro studies carried out in lymphoid cell lines showed the 
ability of cocoa to reduce the synthesis of interleukin 2 (IL-2) 
involved in early T  lymphocyte proliferation (42, 43). This 
cytokine is mainly produced by Th cells after antigen activation 
(44) and plays a crucial role in immune response, enhancing 
Tc cell, NK  cell cytotoxic activities, T  cell differentiation, and 
stimulating the proliferation and the antibody synthesis (45). 
These effects could be responsible for the cocoa downregulation 
of the antibody synthesis. However, the results obtained in vivo 
on IL-2 secretion or lymphocyte proliferation could not confirm 
such a mechanism (18, 21, 30) (Figure 1A). In particular, IL-2 
secretion was not modified in spleen cells from rats fed 10% cocoa 
for 3  weeks, even though lymphocyte proliferation increased 
(18). On the other hand, higher or unmodified amounts of IL-2 
secretion were detected after the stimulation of lymph node cells 
of rats fed a 10% cocoa diet for 3 or 9 weeks (21, 30). Therefore, 
the interaction of a cocoa diet in the initial phases of immune 
activation seems not to explain the attenuating effect on antibody 
synthesis. However, a recent study on the gene expression of mes-
enteric lymph node cells shows that certain molecules present on 
antigen-presenting cells (dendritic cells) were modified by this 
diet. In particular, a cocoa diet increased the gene expression of 
CD11c and OX40L (31) (Figure 1A). It has been suggested that, in 
a model of oral sensitization, a subset of dendritic cells (CD11c+, 
CD103+, and CD8+) that migrates and activates in the mesen-
teric lymph nodes seems responsible for the Th2 polarization in 
this model (46). OX40L–OX40 interaction has been related to 
follicular Th cells and promotes the generation of Th2 response 
during antigen presentation (47, 48), and it was increased in an 
oral sensitization process (31). Despite these results, the cocoa 
FiGURe 1 | Summary of the mechanisms involved by cocoa diet on lymphocyte function: (A) Cocoa effect on the induction of acquired immune response, involving 
from antigen presentation until the development of effector T cells. (b) Cocoa effect on the B-cell activation and antibody production. Arrows indicate increases or 
decreases, equals sign means no changes. Th, T helper cells; Treg, T regulatory cells; IL, interleukin; IFN, interferon; CD, cluster of differentiation.
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diet attenuated the antibody synthesis and, therefore, this diet 
must interact with downstream pathways of the Th2-immune 
responses that would eventually inhibit antibody synthesis.
In general, the cytokine pattern secreted by activated lympho-
cytes reveals the stimulation of Th1, Th2, Th17, or Treg cells (49). 
Interferon γ (IFN-γ) is the most representative cytokine in Th1 
activation (50). No changes were detected either in serum levels 
of IFN-γ in rats fed cocoa for 4 weeks (32) or in the secretion 
of IFN-γ by activated splenocytes or lymph node cells from rats 
fed a cocoa diet for 3 weeks (18) or 4 weeks (31). Nevertheless, 
an increase of IFN-γ was observed in lymph node lymphocytes 
from rats fed a cocoa diet for 8 weeks (21) (Figure 1A). Therefore, 
it seems that a cocoa intake over longer periods promotes Th1 
immune response.
More interesting results were found in IL-4, the most 
representative Th2 cytokine (51). A reduction of IL-4 was 
found in activated lymph node cells from rats fed cocoa for 
3  weeks (30) and in splenocytes from rats fed cocoa for 3 or 
8 weeks (18, 21). However, no changes in IL-4 were found after 
4  weeks of nutritional intervention (31). On the other hand, 
this downregulation on IL-4 secretion did not match with 
previous data in vitro (42, 43, 52) but it partially explains the 
down-modulatory role of the cocoa diet on antibody synthesis 
(Figure  1A). IL-4 promotes IgE upregulation and increases 
intestinal permeability (53, 54); therefore, the decrease in IL-4, 
along with the TCRγδ+ cell increase induced by the cocoa diet, 
may be beneficial in reducing certain stages of hypersensitivity, 
such as food allergy. However, some reports focused on IL-10, 
a regulatory cytokine (55), did not detect any modification by 
the 10% cocoa diet (30, 31).
The effects of cocoa lowering IL-4 secretion in some lym-
phocytes populations agree with those found when the specific 
antibody-secreting cells after an immunization were enumerated. 
A significant decrease in the specific IgG-secreting cell numbers 
was reported by 5 and 10% cocoa diets, either in spleen or lymph 
node tissues, although no changes were observed in specific IgM-
secreting cells (21) (Figure 1B). In summary, a cocoa-enriched 
diet plays an immune-regulatory role in the antibody immune 
response to an antigen that involves a lower number of specific 
antibody-secreting cells and, therefore, a decrease in antibody 
synthesis.
COCOA iNTAKe iNFlUeNCeS 
iNTeSTiNAl iMMUNe SYSTeM
Cocoa intake and intestinal 
immunoglobulins
Several years ago, Ramiro-Puig et  al. first demonstrated that 
a cocoa-enriched diet influences the GALT by means of the 
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modulation of the intestinal secretory IgA (S-IgA) (30). Feeding 
just a 4% cocoa-enriched diet caused a decrease in the fecal S-IgA 
levels in the second week of the diet, but they were restored at 
the end of the third one. The 10% cocoa intervention caused 
lower fecal S-IgA secretion throughout the study (30), and this 
effect remained when the diet was maintained for 7 weeks (19). 
However, when a dose–effect study was performed with diets 
containing 2, 5, or 10% cocoa, the 2% diet was not enough to 
modify intestinal immunoglobulins (20). With regards to the 
gut wash—a typical sample used to evaluate intestinal immu-
noglobulins that consists of incubating the intestine with saline 
buffer at 37°C in a shaker for a few minutes to allow the release 
of the mucosa-linked antibodies—a lower secretion of S-IgA and 
S-IgM was detected (19, 20, 30, 56). These results evidence a lack 
of the S-IgM compensatory mechanism in certain states of S-IgA 
deficiency (57), probably because cocoa is also acting on S-IgM. 
Other studies have confirmed the previous attenuating effect 
of a 10% cocoa diet on S-IgA levels both in fecal samples and 
in gut washes (31, 58). Moreover, the immunoglobulin content 
has also been determined in intestinal tissues, such as Peyer’s 
patches (PP) and mesenteric lymph nodes; and, in both tissues, 
the 10% cocoa diet for 3 weeks was able to decrease the levels of 
IgA and IgM (56).
The downregulation of intestinal immunoglobulins produced 
by a cocoa diet may be due to the influence of some cocoa 
compounds on the complex immune response developed in the 
GALT. This immune compartment includes inductive sites (PP 
and mesenteric lymph nodes) and effector sites [lamina propria 
(LPL) and intraepithelial lymphocytes (IEL)] (59). As explained, 
cocoa intake induced some changes in mesenteric lymph nodes, 
but the cocoa effect is not only restricted to that particular 
compartment. Therefore, further studies were then focused on 
looking in more depth the effect of a cocoa diet on PP as well as 
LPL and IEL.
Cocoa intake and lymphocyte 
Composition in Small intestine and Colon
The attenuation of serum or intestinal immunoglobulin synthe-
sis may be the result of multitude pathways, but the reduction 
of mucosal IgA observed after cocoa dietary intervention may 
possibly involve specific mechanisms located at the intestinal 
site.
The rat intake of 10% cocoa for 4 weeks modified the com-
position of lymphocytes in the PP and in the intraepithelial 
compartment whereas no modifications were seen in LPL (33) 
(Table 2). With regard to PP, cocoa-enriched diets were able to 
reduce the proportion of TCRαβ+ T  cells and to increase the 
proportion of B lymphocytes and TCRγδ+ cells (30, 33), results 
that agree with changes detected in the mesenteric lymph nodes 
(30, 31). Analyzing in depth TCRαβ+ cells in the intestine, the 
cocoa diet decreased the proportion of Th cells and increased 
that of natural killer T  cells (NKT). In addition, after cocoa 
intake, PP also had higher proportions of CD4+CD25+ cells, 
CD4+CD103+ cells, CD8+CD103+ cells, and CD4+CD62L+ cells. 
Apart from the influence of cocoa intake on PP composition, 
the intraepithelial compartment was also affected by this diet. 
In IEL from the small intestine of rats fed cocoa, there was a 
higher percentage of TCRγδ+ cells (both CD8αα+ and CD8αβ+) 
and NK cells (33).
In summary, in the GALT, the lower production of intestinal 
antibodies was accompanied by a relative increase in B  cell 
numbers and a relative decrease in TCRαβ+ or Th cell numbers 
in the inductive sites (mesenteric lymph nodes and PP). These 
results suggest that the antibody synthesis in B cells might be 
depleted by a lower stimulation from Th cells and/or a higher 
regulatory effect induced by cells, such as TCRγδ+, NK, NKT, 
CD4+CD25+, CD4+CD103+, CD8+CD103+, and CD4+CD62L+, 
which is in agreement with the role of some of these cells in the 
regulation of the antibody synthesis (25, 40, 60). In whatever 
way the activation and differentiation of intestinal B cells was 
attenuated, a depletion of the high-capacity IgA-secretory 
cells was produced as reported when they were counted by 
Enzyme-Linked ImmunoSpot in PP (30) or by an immuno-
fluorescence analysis in the small intestine lamina propria 
(33). These results agree with a lower IgA gene expression in 
PP and small intestine seen after 4 and 7 weeks of cocoa intake 
(19, 33).
effects of Cocoa Diet on T Cell-Dependent 
intestinal immune Function
The gene expression of molecules involved in the intestinal 
immune response can shed some light on the mechanisms 
induced by cocoa on the regulation of the intestinal immune 
system. In this context, the mRNA levels of IgA, transforming 
growth factor (TGF) β1, IL-6, CD40, C–C chemokine receptor 
(CCR) 9, retinoic acid receptor (RAR) α, and RARβ have been 
reported in GALT tissues, such as mesenteric lymph nodes, PP, 
and small intestine after 3 or 7 weeks of a cocoa diet (19, 20).
CD40 is involved in the interaction between B and Th cells to 
begin the antibody immune response (61), and cocoa intake did 
not modify the expression of this molecule in any of the tissues 
considered (19, 20) suggesting that cocoa had no influence in this 
phase of the antibody synthesis. The main pathway that brings 
differentiation of B  cells into IgA-secreting cells takes place in 
PP or mesenteric lymph nodes (62) and depends on cytokines, 
such as TGF-β1 and IL-6, among others (63). The 10% cocoa 
diet significantly decreased the TGF-β1 expression in the small 
intestine after 3 and 4 weeks (20, 33), although no changes were 
found after 7 weeks of nutritional intervention (19) (Figure 2). 
On the contrary, the longest nutritional intervention, but not 
the shortest one, was able to downregulate the IL-6 synthesis 
in mesenteric lymph nodes (19, 20). Therefore, the effect on 
these two cytokines, TGF-β1 and IL-6, involved in the S-IgA 
secretion at different periods (64), might be partly responsible 
for the downregulatory effect of cocoa. Neither TGF-β1 nor IgA 
gene expressions were downregulated by the 5% cocoa diet (20), 
which also caused a reduction in intestinal S-IgA, indicating that 
additional mechanisms may be interfering in the intestinal S-IgA 
content.
The next stage occurs when the activated B  cells leave the 
inductor sites (PP and mesenteric lymph nodes) and home to 
the effector sites (i.e., lamina propria), where the differentiation 
FiGURe 2 | Summary of the mechanisms involved by cocoa diet on intestinal immune function in both T-dependent and T-independent pathways. Arrows indicate 
increases or decreases, equals sign means no changes. Ig, immunoglobulin; PP, Peyer’s patches; pIgR, polymeric immunoglobulin receptor; TLR, toll-like receptor; 
CCR, C–C chemokine receptor.
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into IgA plasma cells takes place (65). Intestinal homing is 
regulated, among others, by chemokine-mediated interactions 
including the chemokine receptor CCR9, which binds to CCL25 
and the CCL28 chemokines in the intestine (66). While 3 weeks 
of diet did not modify the expression of the CCR9 receptor 
nor the CCL25 but did increase the expression of CCL28 in 
the small intestine (20), 7  weeks of cocoa diet resulted in a 
downregulation of CCR9 and CCL28 gene expression in the 
same compartment (19) (Figure 2). In addition, retinoic acid 
produced by intestinal dendritic cells also plays a key role in 
gut homing (66) through the interaction with nuclear RAR (67). 
The gene expression of both RARα and RARβ was not modified 
in the intestinal tissue of rats fed cocoa for 3 weeks (20) but both 
decreased after 7 weeks (19) (Figure 2). Overall, these results 
could indicate that after being fed a cocoa diet over a long time 
there was an impairment of the arrival of IgA-secreting cells 
to the intestine because of the lack of gut-homing receptors 
observed. However, they do not explain the early decrease in 
S-IgA that was observed.
Finally, delivering IgA into the intestinal lumen depends on the 
transmembrane epithelial protein polymeric immunoglobulin 
receptor (pIgR) (68). This receptor was not modified by the cocoa 
intake (20), thus indicating that cocoa-induced S-IgA reduction 
did not occur as a consequence of a decreased transport across 
the epithelium.
effects of Cocoa Diet on T Cell-
independent intestinal immune Function
Apart from these IgA-secreting mechanisms that depend on 
T-cell activation, IgA+  B  cells can be alternatively generated in 
a T-cell-independent manner involving toll-like receptor (TLR) 
signaling.
The gene and protein expression of other TLR has been 
modified both in the inductive sites of GALT (PP and mesenteric 
lymph nodes) and the effector sites (intestinal wall) after cocoa 
intake (19, 20, 33). In this context, among other components 
present in the cocoa, flavonoids have been suggested as dietary 
factors able to modulate TLR-mediated signaling pathways (69). 
TLR pathways can be modulated by flavonoids at different levels, 
and there are evidences of several flavonoids interfering at gene/
protein expression level, in subsequent activation pathways such 
as the myeloid differentiation primary response 88 (MyD88), 
TIR-domain-containing adaptor protein inducing interferon beta 
(TRIF), and even downstream-associated signal transduction 
cascades (i.e., MAPK) (69). In this sense, alternative mechanisms 
in TLR regulation by cocoa flavonoids have been also suggested 
such as the direct modulation of their intracellular negative 
regulators such as the interleukin-1 receptor associated kinase 
(IRAK), toll interacting protein (TOLLIP), etc. To date, in vitro 
studies demonstrate the upregulation of IRAK-M by procyanidin 
dimer B2 (70), similarly to the effect described by other flavonoids 
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like epigallocatechin-galate in TOLLIP expression (70). Anyway, 
the synergistic action of cocoa on all these TLR-activating signal-
ing could also contribute to the attenuation of S-IgA synthesis.
Cocoa intake for 4 weeks reduced the proportion of TLR4+ 
cells in the IEL compartment (33) which agrees with a decrease 
of TLR4 mRNA in small intestine observed in previous studies 
(Figure 2). Nonetheless, higher TLR4 gene expression was found 
in PP (19). The TLR4 is the receptor of bacterial endotoxin 
lipopolysaccharide, and its signaling has implications for IgA 
production (71), becoming another pathway to attenuate intes-
tinal S-IgA synthesis.
Toll-like receptors are expressed preferentially in tissues 
that are in constant contact with microorganisms (72, 73), and 
changes in the TLR expression induced by flavonoids could 
reflect changes in the intestinal microbiota and/or in its relation 
with intestinal immune cells (69, 74). Accordingly, several studies 
have shown that cocoa (58, 75, 76), cocoa flavonoids (58, 77), or 
cocoa fiber (78) induce changes in gut microbiota composition. 
Moreover, a lower proportion of IgA-coated bacteria have been 
observed after cocoa intake (79).
In summary, it could not be discarded that the influence of 
cocoa on GALT was partially mediated by its effect on the intesti-
nal microbiota, which can lead to differential TLR activation and, 
therefore, may also influence the lowering IgA effect of cocoa.
Recently, an analysis of an untargeted 1H NMR spectroscopy-
based metabolomic approach in 24-h urine samples have been 
carried out in order to correlate urine cocoa metabolites with 
cocoa effects on immunity and the gut microbiota (80). The 
results of this analysis demonstrate that cocoa intake, besides 
affecting microbiota composition, also alters the host and bacte-
rial metabolism concerning energy and amino acid pathways 
leading to a particular metabolic signature that correlates with the 
S-IgA lowering effect of cocoa. Accordingly, a different pattern 
of intestinal and serum short-chain fatty acids, with increasing 
amounts of butyric acid, has been reported (78).
Finally, and in order to have a broader view of the molecules 
involved in the intestinal immune response modulated by 
cocoa, the changes in colonic gene expression by a microarray 
analysis after a cocoa nutritional intervention has been carried 
out (81). This study shows that a cocoa diet downregulated an 
extensive number of genes, many of them involved in the biologi-
cal processes related to the immune system and inflammation. 
Specifically, the most downregulated gene after cocoa intake was 
tachykinin 4 (81), described as the promoter of B lineage cells 
(82), which could explain the attenuating effect of cocoa on anti-
body synthesis, despite the fact that the proportion of B cells did 
not decrease but, on the contrary, increased in some lymphoid 
tissues. Moreover, other genes involved in pathways related to the 
mast cell-mediated immunity, its activation, and its degranula-
tion were downregulated (81), pointing out the possible role of 
cocoa in inducing tolerance in allergic processes as observed in 
some studies next reported.
Cocoa intake Also influences Another 
Mucosal lymphoid Tissue
The mucosal immune system is interconnected (59). Due to 
cocoa’s influence on the intestinal immune system, it became of 
interest to know whether this effect was also extended to other 
mucosal compartments, such as the salivary glands. The IgA and 
IgM content in the salivary glands (submaxillary and parotid 
salivary glands) was quantified after a 10% cocoa intake in rats 
for 3 weeks. The cocoa diet induced a decrease in the IgA and IgM 
content in both glands (56). This attenuating effect was associated 
with a drastic reduction in the IgA gene expression together with 
a lower expression of some molecules involved in the maturation 
and differentiation of B cells, such as IL-6 and TGF-β1 (56), as 
previously observed in the small intestinal samples (19, 20). 
However, in agreement with what was detected at intestinal level, 
no changes were detected in pIgR gene expression in the salivary 
glands. Therefore, in conclusion, this study shows that cocoa intake 
not only has an influence on the gut intestinal compartment and 
the systemic immunity but also on other mucosal sites in rats.
eFFeCT OF COCOA DieT ON ANTibODY-
MeDiATeD DiSeASeS
Due to the attenuating properties of cocoa on immunoglobulin 
levels after cocoa intake in rats, it was of interest to test its impact 
on diseases in which antibodies play a harmful effect. Therefore, 
this nutritional intervention was tested on animal models of 
arthritis and allergy.
effect of Cocoa Diet on experimental 
Arthritis
Rheumatoid arthritis is a symmetric, polyarticular, systemic, and 
autoimmune inflammatory disease in which multiple factors, 
including genetic, immune, and environmental ones are involved 
(83). Diet components such as n-3 fatty acids, vitamins D and K, 
and antioxidants are protective compounds against rheumatoid 
arthritis (84). In this context, diets containing 5 or 10% cocoa 
were tested on adjuvant arthritis, a model of rheumatoid arthritis 
widely used for the screening of anti-inflammatory drugs (85). In 
this animal model, cocoa diet decreased the synthesis of antibod-
ies against the pathology inducer (Table 3) and was also able to 
decrease the proportion of Th cells in both blood and regional 
lymphoid tissues (86). This latter effect is important because, 
as anti-CD4 therapy has been shown to prevent or ameliorate 
adjuvant arthritis (87, 88), the cocoa-induced decrease in Th 
cells could be beneficial to the arthritic process. Moreover, a 10% 
cocoa diet avoided the Th/Tc imbalance and the reduction of the 
proportion of NKT cells produced by the disease (86). However, 
the effect of cocoa on hind-paw inflammation was very poor (86), 
which did not agree with the protective effect of other flavonoids 
in a similar inflammatory model when given by oral (quercetin) 
or by intraperitoneal routes (quercetin, rutin, hesperidin, and 
morin) (89–91). Nevertheless, a cocoa extract inhibited mice ear 
edema (92) and acute paw edema in rat (93, 94). Moreover, cocoa 
flavonoids such as epicatechin, catechin, and procyanidin B2, 
among others, are able to attenuate the synthesis of inflamma-
tory mediators, such as tumor necrosis factor (TNF)-α, monocyte 
chemoattractant protein-1, IL-6, and IL-8 (95–100).
The influence of a 10% cocoa diet was also analyzed in 
colla gen-induced arthritis, another model of arthritis. This 
TAble 3 | Summary of the effects of cocoa diet in specific antibodies in rat 
models of arthritis and allergy.
Model Strain Cocoa 
dose
Results Reference








Louvain 5–10% in 
the food
=Specific IgG1 (32)




















↓ specific IgG1, IgG2a (101)
=Specific IgG2b
↓Specific IgE
Oral sensitization Lewis 10% in 
the food
↓Specific IgG1, IgG2b (31)
↓Specific IgM
Ig, immunoglobulin.
Arrows indicate increases or decreases, equals sign means no changes.
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inflammatory model requires T- and B-cell responses to 
autologous collagen (102). B cells from animals with collagen-
induced arthritis produce a strong specific immune response 
against triple helical epitopes of collagen type II (103). Anti-
collagen autoantibodies bind to the joint cartilage, activate the 
complement cascade, and mediate the inflammatory attack on 
the joints, thus contributing to the disease development (104). 
Susceptible Louvain rats were fed with a 10% cocoa diet for 
2 weeks before arthritis induction and during the latency period 
(2 weeks after induction), and thereafter with a 5% cocoa diet 
until the end of the study (an additional 2 weeks). In this case, the 
cocoa-enriched diet was able to reduce the synthesis of specific 
antibodies against type II collagen, differentially according to 
their isotype (Table 3), decrease the Th lymphocyte proportion 
in regional lymph nodes, and reduce the release of inflamma-
tory mediators from peritoneal macrophages. However, these 
immunomodulatory effects were not enough to reduce the 
hind-paw swelling in arthritic animals (32). It must be taken 
into account that the decrease in anti-collagen antibody con-
centration in that rat strain was only observed at the end of the 
study, and it was in a lesser extent and more slowly than that 
expected and observed in healthy rats as shown before. In a 
similar context, other authors reported the beneficial effect of 
isolated flavonoids in improving the paw swelling in animals in 
long-term studies (105–107). Otherwise a nutritional interven-
tion with the flavonoid genistein had no success (108).
effect of Cocoa Diet on Hypersensitivity 
Animal Models
Cocoa on Allergy Models
The effect of the consumption of a 10% cocoa diet over 4 weeks 
was studied in a model of allergy induced by an intraperitoneal 
(i.p.) injection of ovalbumin (OVA) and toxin of Bordetella 
pertussis in alum in young Brown Norway rats (22). The cocoa 
diet reduced the levels of anti-OVA IgG1 and IgG2a antibodies 
(Table 3), i.e., immunoglobulins related to Th2-immune response 
in rats, as previously mentioned. In addition, cocoa consump-
tion decreased the serum concentrations of total and specific 
IgE (Table  3), which is the main immunoglobulin involved in 
allergic reactions. These results agree with studies performed 
in animal models of allergy treated with polyphenols, such as 
baicalein (109), quercetin (110), silibinin (111), sesamin (112), or 
an extract of Kalanchoe pinnata (Crassulaceae) containing several 
flavonoids such as quercetin (113).
To analyze the mechanisms involved in such action, cytokine 
secretion was quantified in mesenteric lymph nodes. Contrary 
to what was expected, cocoa diet increased the release of IL-4, 
a Th2 cytokine, and decreased that of IL-10, a cytokine related 
to immune-regulatory responses (22). In addition, cocoa intake 
induced a lower secretion of TNF-α, which has been described 
as a contributor to the development of Th2-mediated allergic 
inflammation by means of promoting the homing of Th2 cells 
to the site of allergic inflammation. These effects of IL-10 and 
TNF-α agree with those reported by other flavonoids in allergic 
conditions (113–115).
The influence of cocoa on the GALT makes it particularly 
interesting to test the effect of this nutritional intervention on 
a food allergy process. A model of food allergy using OVA as 
allergen was carried out in Brown Norway rats, combining an 
i.p. and oral administration of the allergen. The quantification of 
serum anti-OVA IgG1, IgG2a, and IgE antibodies revealed that 
the synthesis of these antibodies was completely prevented by the 
cocoa diet (101) (Table 3). In this study, a product that was richer 
in cocoa flavonoids was included, but it was not able to totally 
reproduce the same effects as the conventional cocoa-enriched 
diet. Therefore, it seems that cocoa flavonoids are only partially 
responsible for cocoa’s anti-allergy properties.
In addition, after anaphylactic shock, the increase of the serum 
mast cell protease II was partially prevented in the allergic group 
fed a cocoa diet (101). Nevertheless, other markers of anaphylaxis 
were not modified by the cocoa intake (body temperature and 
motor activity), suggesting that its modifications were not enough 
to prevent the food allergy reaction induced (101).
In order to shed light on cocoa’s anti-allergy properties, the 
expression of some small intestinal genes were quantified (101). 
The food allergy induction increased the IgA gene expression, 
an effect that was prevented by a cocoa diet. Moreover, the 
allergic animals fed a cocoa diet also had lower mRNA levels 
of high-affinity IgE receptors (FcεRI), mast cell protease-II, 
and TGF-β1 than reference animals, molecules which could 
be involved in the protective effect of cocoa on food allergy. 
Accordingly, the inhibitory effects of flavonoids on the FcεRI 
surface molecule or gene expression in  vitro were described 
(116, 117), and the genetic analysis of colon from rats fed cocoa 
assessed by microarray analysis showed the downregulation of 
genes involved in pathways related to mast cell activation and 
degranulation (81). The cytokine production of food-allergic 
animals was also determined in mesenteric lymph nodes 
and spleen (101). In these tissues, the food allergy induction 
increased the secretion of Th2-cytokines, such as IL-4, IL-5, 
and IL-13. However, the cocoa diet prevented an increase in 
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IL-5 and IL-13 in lymph node cells and that of IL-4 and IL-13 
in splenocytes.
In conclusion, in models of Th-2 immune response stimula-
tion, the intake of cocoa prevents the secretion of typical Th2-
cytokines, the synthesis of IgE involved in mast cell degranulation, 
and also downregulates the IgE receptors in mast cells and 
intestinal mast cell activation, which are the cells responsible for 
the most allergy symptoms. However, such effects were not able 
to totally prevent anaphylactic shock.
Cocoa on an Oral Sensitization Model
Although cocoa intake prevented the allergic sensitization in a 
model of food allergy induced by i.p. and oral allergen admin-
istration (101), it remained to find out what happened when 
the sensitization with the allergen was produced using only the 
oral route. Therefore, a 10% cocoa-enriched diet was given to 
3-week-old Lewis rats submitted to an oral sensitization model 
induced by the oral administration of OVA together with the 
cholera toxin (CT) as adjuvant (118). The oral administration 
of OVA/CT, three times per week and for 3 weeks, was able to 
break down oral tolerance and induce the synthesis of specific 
antibodies after 4 weeks from the beginning of the sensitization 
protocol. Although this model did not induce detectable specific 
IgE synthesis, Th2-immune response related antibodies were 
produced (118) (Table 3). Feeding 10% cocoa from the beginning 
of the study and throughout 4 weeks attenuated the development 
of specific antibodies in sensitized rats fed the cocoa diet (31). In 
particular, the 10% cocoa diet prevented the production of anti-
OVA IgG1, IgG2b, and IgM in agreement with the effect of cocoa 
in a food allergy model in Brown Norway rats (101).
In addition, although the IgA concentrations were not 
increased in this rat oral sensitization model, in contrast to 
other models using the same adjuvant (63, 119), the cocoa diet 
decreased the total IgA in both serum and intestinal compart-
ments. As stated in previous sections, a cocoa diet influences 
the proliferation, differentiation, and gut homing of IgA+ B cells 
(19, 31, 33), thus inducing a lower presence of these cells in the 
intestinal lamina propia (33) and, consequently, reducing the 
intestinal IgA development in line with what was reported in 
many studies (20, 79, 101). Additionally, the changes produced 
by the cocoa diet in both inductive and effector lymphoid tis-
sues (see Cocoa Intake and Lymphocyte Composition in Small 
Intestine and Colon) might be responsible for the prevention 
of the oral sensitization. It is worth noting that the cocoa diet 
increased the proportion of TCRγδ+ and NK  cells in three 
intestinal compartments (mesenteric lymph nodes, PP, and IEL), 
suggesting their role in the tolerogenic process. In line with this, 
unripe apple polyphenols induced an increase in the proportion 
of TCRγδ+ IEL in association with the inhibition of the develop-
ment of an oral sensitization model (25), and it was also reported 
that the reduction of TCRγδ+ cells by the anti-TCRγβ antibody 
favors an oral sensitization in mice (120). Furthermore, NK cells 
could have regulatory functions contributing to the avoidance 
of sensitization in line with the reported prevention of allergic 
disease (121, 122).
Other changes induced by a cocoa diet could contribute to 
its tolerogenic effect (31, 33). Such changes include a reduced 
proportion of Th cells in mesenteric lymph nodes, PP in IEL, 
an increase in the percentage of CD103+ cells, a reduction of 
CD62L+ cells, and an increase in the percentage of CD25+ cells 
in PP. Cocoa intake also modulated the gene expression of 
several molecules both in mesenteric lymph nodes and in the 
small intestine (31, 33). In particular, cocoa consumption was 
associated with an increase in the gene expression of CD11c—a 
dendritic cell marker (123)—in mesenteric lymph nodes, 
whereas the mRNA levels of CD11c and CD11b were reduced in 
small intestinal samples; cocoa also upregulated the expression 
of OX40L in mesenteric lymph nodes (31)—mainly expressed 
on antigen-presenting cells (124). In this sense, the interaction 
of OX40–OX40L regulates cytokine production from T  cells, 
antigen-presenting cells, NK  cells, NKT  cells, and cytokine 
receptor signaling (125). Additionally, cocoa decreased the 
gene expression of IL-1β—a potent pro-inflammatory cytokine 
(126)—in mesenteric lymph nodes, although no modifications 
were seen in the production of Th1 (IFN-γ and TNF-α), Th2 
(IL-4), or Treg (IL-10) cytokines.
Overall, a cocoa intake, by means of its influence on the 
intestinal immune system, is able to avoid the sensitization to 
oral allergens, thus contributing to the downregulation of this 
hypersensitivity reaction.
Cocoa on an Atopic Dermatitis Model
Recently the role of a cocoa extract on atopic dermatitis has 
been published (127). The cocoa extract decreased the IgE levels 
induced by a Dermatophagoides farinae extract together with a 
reduction of atopic dermatitis symptoms. Particularly, the cocoa 
decreased the severity of the skin lesions, the loss of skin hydra-
tion and suppressed the infiltration of eosinophils and mast cells 
into the skin lesions. Moreover, an extract containing 0.25% cocoa 
downregulated IL-4 mRNA levels on the skin tissues, whereas an 
extract containing 1% cocoa decreased IL-5 gene expression at 
this level.
CONClUSiON
In this review, we summarize the effect of a cocoa diet on the 
immune system of rats, particularly in the antibody response, 
both in systemic and mucosal (intestinal and extraintestinal) 
compartments. The analyses of cells involved in such responses, 
as well as molecules, such as cytokines and receptors, dem-
onstrate that the effects of a cocoa diet are exerted at multiple 
sites: in the antigenic presentation, in the cytokines produced by 
effector Th cells, and in the intestinal homing of activated cells. 
Eventually, these actions will reduce the synthesis of most anti-
body isotypes, in particular Th2-associated antibodies as IgE. The 
relative decrease of Th lymphocytes associated with an increase 
in TCRγδ+ cells and NK cells detected in most lymphoid tissues 
studied suggest the involvement of these cells in the regulatory 
role of cocoa. The immunomodulatory potential of cocoa can 
be very beneficial in those diseases that involve hypersensitivity, 
such as allergy and autoimmune diseases. Nevertheless, although 
no signs of immunodeficiency were observed in the described 
studies, it must be considered that the attenuation of antibod-
ies can be harmful when antibodies are needed to counteract a 
11
Camps-Bossacoma et al. Cocoa Diet and Antibody Response
Frontiers in Nutrition | www.frontiersin.org June 2017 | Volume 4 | Article 28
ReFeReNCeS
1. Chaplin DD. Overview of the immune response. J Allergy Clin Immunol 
(2010) 125:S3–23. doi:10.1016/j.jaci.2009.12.980 
2. El Shikh MEM, Pitzalis C. Follicular dendritic cells in health and disease. 
Front Immunol (2012) 3:292. doi:10.3389/fimmu.2012.00292 
3. Heesters BA, Chatterjee P, Kim YA, Gonzalez SF, Kuligowski MP, 
Kirchhausen T, et  al. Endocytosis and recycling of immune complexes by 
follicular dendritic cells enhances B  cell antigen binding and activation. 
Immunity (2013) 38:1164–75. doi:10.1016/j.immuni.2013.02.023 
4. Kranich J, Krautler NJ. How follicular dendritic cells shape the B-cell anti-
genome. Front Immunol (2016) 7:225. doi:10.3389/fimmu.2016.00225 
5. Lippi D. Chocolate in history: food, medicine, medi-food. Nutrients (2013) 
5:1573–84. doi:10.3390/nu5051573 
6. De Araujo QR, Gattward JN, Almoosawi S, Silva M, Dantas PA, De Araujo 
Junior QR. Cocoa and human health: from head to foot – a review. Crit Rev 
Food Sci Nutr (2016) 56:1–12. doi:10.1080/10408398.2012.657921 
7. Grassi D, Desideri G, Mai F, Martella L, De Feo M, Soddu D, et al. Cocoa, 
glucose tolerance, and insulin signaling: cardiometabolic protection. J Agric 
Food Chem (2015) 63:9919–26. doi:10.1021/acs.jafc.5b00913 
8. Ellam S, Williamson G. Cocoa and human health. Annu Rev Nutr (2013) 
33:105–28. doi:10.1146/annurev-nutr-071811-150642 
9. Kampa M, Theodoropoulou K, Mavromati F, Pelekanou V, Notas G, 
Lagoudaki ED, et  al. Novel oligomeric proanthocyanidin derivatives 
interact with membrane androgen sites and induce regression of hormone- 
independent prostate cancer. J Pharmacol Exp Ther (2011) 337:24–32. 
doi:10.1124/jpet.110.177246 
10. Martin MA, Goya L, Ramos S. Potential for preventive effects of cocoa 
and cocoa polyphenols in cancer. Food Chem Toxicol (2013) 56:336–51. 
doi:10.1016/j.fct.2013.02.020 
11. Rodríguez-Ramiro I, Ramos S, López-Oliva E, Agis-Torres A, Gómez-
Juaristi M, Mateos R, et al. Cocoa-rich diet prevents azoxymethane-induced 
colonic preneoplastic lesions in rats by restraining oxidative stress and cell 
proliferation and inducing apoptosis. Mol Nutr Food Res (2011) 55:1895–9. 
doi:10.1002/mnfr.201100363 
12. Goya L, Martín MÁ, Sarriá B, Ramos S, Mateos R, Bravo L. Effect of cocoa 
and its flavonoids on biomarkers of inflammation: studies of cell culture, 
animals and humans. Nutrients (2016) 8:1–22. doi:10.3390/nu8040212 
13. Pérez-Cano FJ, Massot-Cladera M, Franch A, Castellote C, Castell M. 
The effects of cocoa on the immune system. Front Pharmacol (2013) 4:71. 
doi:10.3389/fphar.2013.00071 
14. Ramiro-Puig E, Castell M. Cocoa: antioxidant and immunomodulator. 
Br J Nutr (2009) 101:931–40. doi:10.1017/S0007114508169896 
15. Ellinger S, Stehle P. Impact of cocoa consumption on inflammation 
processes – critical review of randomized controlled trials. Nutrients (2016) 
8:1–26. doi:10.3390/nu8060321 
16. Castell M, Saldaña-Ruíz S, Rodríguez-Lagunas MJ, Franch À, Pérez-Cano FJ. 
Second international congress on chocolate and cocoa in medicine held in 
Barcelona, Spain, 25-26th September 2015. Nutrients (2015) 7:9785–803. 
doi:10.3390/nu7125502 
17. Massot-Cladera M, Pérez-Cano F, Llorach R, Urpi-Sarda M. ‘Cocoa and 
chocolate: science and gastronomy’. The second annual workshop of the 
Research Institute on Nutrition and Food Security (INSA): 9 November 2016. 
Nutrients (2017) 9:156. doi:10.3390/nu9020156 
18. Ramiro-Puig E, Pérez-Cano FJ, Ramírez-Santana C, Castellote C, 
Izquierdo-Pulido M, Permanyer J, et  al. Spleen lymphocyte function 
modulated by a cocoa-enriched diet. Clin Exp Immunol (2007) 149:535–42. 
doi:10.1111/j.1365-2249.2007.03430.x 
19. Pérez-Berezo T, Franch A, Castellote C, Castell M, Pérez-Cano FJ. Mechanisms 
involved in down-regulation of intestinal IgA in rats by high cocoa intake. 
J Nutr Biochem (2012) 23:838–44. doi:10.1016/j.jnutbio.2011.04.008 
20. Pérez-Berezo T, Franch A, Ramos-Romero S, Castellote C, Pérez-Cano FJ, 
Castell M. Cocoa-enriched diets modulate intestinal and systemic humoral 
immune response in young adult rats. Mol Nutr Food Res (2011) 55(Suppl 1): 
S56–66. doi:10.1002/mnfr.201000588 
21. Pérez-Berezo T, Ramiro-Puig E, Pérez-Cano FJ, Castellote C, Permanyer J, 
Franch A, et  al. Influence of a cocoa-enriched diet on specific immune 
response in ovalbumin-sensitized rats. Mol Nutr Food Res (2009) 53:389–97. 
doi:10.1002/mnfr.200700396 
22. Abril-Gil M, Massot-Cladera M, Pérez-Cano FJ, Castellote C, Franch A, 
Castell M. A diet enriched with cocoa prevents IgE synthesis in a rat allergy 
model. Pharmacol Res (2012) 65:603–8. doi:10.1016/j.phrs.2012.02.001 
23. Kogiso M, Sakai T, Mitsuya K, Komatsu T, Yamamoto S. Genistein suppresses 
antigen-specific immune responses through competition with 17beta-estra-
diol for estrogen receptors in ovalbumin-immunized BALB/c mice. Nutrition 
(2006) 22:802–9. doi:10.1016/j.nut.2006.04.003 
24. Yano S, Umeda D, Yamashita T, Ninomiya Y, Sumida M, Fujimura Y, et al. 
Dietary flavones suppresses IgE and Th2 cytokines in OVA-immunized 
BALB/c mice. Eur J Nutr (2007) 46:257–63. doi:10.1007/s00394-007-0658-7 
25. Akiyama H, Sato Y, Watanabe T, Nagaoka MH, Yoshioka Y, Shoji T, 
et  al. Dietary unripe apple polyphenol inhibits the development of food 
allergies in murine models. FEBS Lett (2005) 579:4485–91. doi:10.1016/j.
febslet.2005.07.019 
26. Ceredig R. The impact of cell re-entry into the primary lymphoid organs on 
lymphocyte repertoire and functionality. Immunol Cell Biol (2009) 87:13–5. 
doi:10.1038/icb.2008.91 
27. Boehm T, Bleul CC. The evolutionary history of lymphoid organs. Nat 
Immunol (2007) 8:131–5. doi:10.1038/ni1435 
28. Urpi-Sarda M, Ramiro-puig E, Khan N, Ramos-romero S, Llorach R, 
Castell M, et  al. Distribution of epicatechin metabolites in lymphoid 
tissues and testes of young rats with a cocoa-enriched diet. Br J Nutr (2010) 
103:1393–7. doi:10.1017/S0007114509993473 
29. Ramiro-Puig E, Urpí-Sardà M, Pérez-Cano FJ, Franch A, Castellote C, 
Andrés-Lacueva C, et al. Cocoa-enriched diet enhances antioxidant enzyme 
activity and modulates lymphocyte composition in thymus from young rats. 
J Agric Food Chem (2007) 55:6431–8. doi:10.1021/jf070487w 
30. Ramiro-Puig E, Pérez-Cano FJ, Ramos-Romero S, Pérez-Berezo T, 
Castellote C, Permanyer J, et  al. Intestinal immune system of young rats 
influenced by cocoa-enriched diet. J Nutr Biochem (2008) 19:555–65. 
doi:10.1016/j.jnutbio.2007.07.002 
31. Camps-Bossacoma M, Abril-Gil M, Saldaña-Ruiz S, Franch À, Pérez- 
Cano FJ, Castell M. Cocoa diet prevents antibody synthesis and modifies 
lymph node composition and functionality in a rat oral sensitization model. 
Nutrients (2016) 8:1–17. doi:10.3390/nu8040242 
32. Ramos-Romero S, Pérez-Cano FJ, Pérez-Berezo T, Castellote C, 
Franch A, Castell M. Effect of a cocoa flavonoid-enriched diet on experi-
mental autoimmune arthritis. Br J Nutr (2012) 107:523–32. doi:10.1017/
S000711451100328X 
pathogenic antigen, such as infections, and to induce antibody-
dependent cytotoxicity, phagocytosis, and complement activa-
tion. Although further research must characterize the particular 
cocoa components responsible for such effects, and nutritional 
studies in humans need to be carried out, cocoa has potential as 
a nutraceutical agent in some hypersensitivity status.
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